Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...

If you have high ALT levels — a liver enzyme known as alanine aminotransferase — it may be due to a liver problem. Here's what you need to know about these liver enzymes and how to lower your ALT ...

Shares of Altimmune, Inc. (ALT) jumped 16% in premarket trading on Friday after it reported positive topline results from its ...

Routine blood tests are increasingly detecting elevated liver enzymes, which may signal liver stress or damage. While mild ...

TAMPA, Fla. (WFLA) — Whenever you get bloodwork done, you probably don’t know what exactly you’re supposed to be looking at on the sheet (unless you’re a healthcare provider, that is). Glucose, sodium ...

Altimmune reports positive 48-week Phase 2b data for pemvidutide in MASH, showing fibrosis improvement, weight loss, and strong tolerability.

Patients with nonalcoholic fatty liver disease may have normal alanine aminotransferase levels in spite of having advanced fibrosis, according to a new study. Patients with nonalcoholic fatty liver ...

Please provide your email address to receive an email when new articles are posted on . Patients with hepatitis B had a higher risk for hepatocellular carcinoma after HBV e antigen seroclearance if ...

November 2, 2006 (Boston) — The currently accepted upper limit of normal for serum alanine aminotransferase (ALT) levels is "artificially high," officials from the American Association for the Study ...

ALT shares drop over 20% after updated pemvidutide week 48 data; see FDA's stance on non-invasive fibrosis tests. Click here ...

GAITHERSBURG, Md., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced a preclinical data presentation on ALT-801, its balanced ...